Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
EVOK > SEC Filings for EVOK > Form 8-K on 8-Oct-2013All Recent SEC Filings

Show all filings for EVOKE PHARMA INC



Other Events

Item 8.01 Other Events.

On October 8, 2013, Evoke Pharma, Inc. (the "Company") closed the full exercise of the over-allotment option granted to the representative of the underwriters to purchase an additional 315,000 shares of its common stock, at a price to the public of $12.00 per share, in connection with the Company's recently announced underwritten initial public offering (the "Offering"). This exercise brings the total shares of common stock issued in the Offering to 2,415,000, and total gross proceeds from the Offering to $28,980,000, before underwriting discounts and commissions and offering expenses payable by the Company. Aegis Capital Corp. acted as sole book-running manager for the Offering. Cantor Fitzgerald & Co. and Feltl and Company, Inc. acted as co-managers for the Offering.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on September 24, 2013.

  Add EVOK to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for EVOK - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.